Thymosin Alpha-1 is an immunomodulatory peptide derived from the thymus gland. It is used clinically in several countries for viral infections, cancer, and immune deficiency.
Enhances T-cell differentiation and maturation, boosts dendritic cell function, and upregulates cytokines involved in immune surveillance.
Minimal. Occasional mild injection site reactions.
1.6 mg SubQ twice weekly for 4–8 weeks during acute illness or immune support protocols.